Hershey Trust CO Aligos Therapeutics, Inc. Transaction History

Hershey Trust CO

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 13, 2022	SELL	$2.08 - $12.2 $3,142 - $18,434	-1,511 Reduced 24.92%	4,552 $10,000
Q2 2021 Aug 11, 2021	BUY	$20.3 - $33.6 $123,078 - $203,716	6,063 New	6,063 $124,000

240K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $751M
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Hershey Trust CO, based on Form 13F filings with the SEC.

Stay updated on Hershey Trust CO with notifications on news.